Cached score snapshot

US.LH · Labcorp

110分制 60.7/110;5D動能v2 9/50;排序分 69.7/160

Ranking score 69.7/160
Main score 60.7/110
5D momentum v2 9/50
Rank #196
Setup grade B 68

Score breakdown

觀望

Medium twelvedata

Score and price trend

B 68 Money flow A · lift 1.37x

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 07-24 09-04 10-19 11-09 11-27 $277.33$316.22$355.11 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.538 · anchors 120 +0.10% -2.21% / +3.41% 52.5% 2.5% Actual +1.82% · vs median +1.72% · inside 25-75 band
30D observation +0.35% -3.48% / +2.06% 55% 22.5% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 -0.17% -2.02% / +2.05% 48.8% 5% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-07-24 → 2026-11-27 · 119 archived points · 1 Improving turn signal · 3 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 69.7
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 60.7/110 (觀望)
5D momentum v2 9/50 (弱)
Score with momentum v2 69.7/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 312.144
ma50 320.4298
close 317.95
prevClose 325.07
avgVolume20 716460
volumeRatio 0.99
changePercent -2.19

Metrics snapshot

close 317.95
volume 706000
changePercent -2.19

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 60.7/110
Main rating 觀望
5D momentum v2 9/50
Score with momentum v2 69.7/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.3/5 · 一般

Dimension score 3.3/5
Dimension grade 一般

Sub-items

pbPoints 0.4
pePoints 0.2
epsPoints 0.6
roePoints 0.4
debtPoints 0.4
marginPoints 0
turnoverUsdM 224.4727
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 15.6/20 · 良好

Dimension score 15.6/20
Dimension grade 良好

Sub-items

cmfPoints 1.6
mfiPoints 4
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.LH
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 8/15 · 較差

Dimension score 8/15
Dimension grade 較差

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 16.46

trend

score 0.8

details

qqq

ma20 742.519
ma50 726.7734
name QQQ
close 709.8
points 0.4

spy

ma20 771.184
ma50 768.5018
name SPY
close 763.25
points 0.4
source twelvedata+fred
atrPct 1.9754
atrPoints 4
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 0.8

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 4
catalystCount 0
catalystPoints 2

風險管理 — 7.6/10 · 良好

Dimension score 7.6/10
Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 1.9754
turnoverUsdM 224.4727
liquidityPoints 0.4
volatilityPoints 1.2
rrPoints 1.6

stopLevels

symbol US.LH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 305.3886

strength_details

ma_score 1
atr_score 2.5
rsi_score 3
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.6
stop_loss_percent 4
take_profit_price 337.5249
target_multiplier 2.2
technical_strength 2.13
take_profit_percent 6.2
positionPoints 1.6
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.5693
stopLossPercent 3.9507
diversificationPoints 2

技術信號 — 20.2/30 · 一般

Dimension score 20.2/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 0.4
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 0.4
vcp_reason 靠近20日高位;Ready=N;Confirm=N

vcp_metrics

up_days 7
vol_ref 755796.6667
down_days 2
vcp_ready false
above_ma50 false
avg_vol_10 611480
avg_vol_20 768055
avg_vol_30 755796.6667
range_pct_10 0.0706
range_pct_20 0.0706
range_pct_30 0.1039
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.8091
dist_to_20d_high 0.0221
down_shrink_days 2
breakout_level_20d 325.15
vcp_breakout_confirm false
contraction_ratio_10_30 0.6794
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.8
rsiKdjPoints 4
volumeWeight 2
maCrossPoints 0
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 4
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.6

sentimentData

raw {"id":142927482,"url":"https://finnhub.io/api/news?id=b3b6b829857bedfcd9e84d185005325194c4788fb14eb827248ae76412b9348f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings has delivered a strong share price run in recent years, so the key issue now is whether the current US$325.07 level is properly supported by the cash it can generate. With investors already sitting on sizeable gains, the question is how closely the recent price action lines up with the company’s underlying cash flow profile. Over the past 3 years the stock has returned 68.8%. This puts real weight on whether that gain aligns with the cash the business is expected to produce...","category":"company","datetime":1792113319,"headline":"Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook"}, {"id":142920665,"url":"https://finnhub.io/api/news?id=4cb99e4b164b6740ed4f3e1f3c25186c3c2160f5ed96c9f49ac720543e3359a9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and its peers.","category":"company","datetime":1792080507,"headline":"Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks"}, {"id":142823840,"url":"https://finnhub.io/api/news?id=ad666a9d8ce474aecb716a215046443d84cf1dca9d4edddca50d373c693188e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug development. Physicians, hospitals, and pharmaceutical companies provide different sources of demand, while personalized treatments create opportunities for more sophisticated testing. Capturing that demand requires spending on equipment, technology, and capacity before the resulting cash arrives. Insider Monkey lists […]","category":"company","datetime":1791828498,"headline":"Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?"}, {"id":142356836,"url":"https://finnhub.io/api/news?id=fcbc25354f9fd091ac16986cc1e363a23ffce42f65a596ab4b5705eba6055c7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings (NYSE:LH) used its 2026 Investor Day to outline a push into targeted acquisitions and new lab technologies. Management emphasized capital deployment toward advanced lab management systems and expanded digital experiences for patients and providers. The company highlighted plans to integrate acquired platforms with its existing diagnostic infrastructure to streamline operations and data handling. Labcorp's renewed focus on acquisitions and digital lab tools only tells part of...","category":"company","datetime":1790162032,"headline":"Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day"}
raw_source {"id":142963267,"url":"https://finnhub.io/api/news?id=e20118b395c1fcab44866a321e7779c08eee6a67d07be0aaff04f641386c736e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"OPKO Health (OPK) drew fresh attention after agreeing to sell select BioReference Health assets to Labcorp in a deal valued at up to US$872 million, a move that could reshape its diagnostics footprint and capital allocation priorities. The deal news arrived after a choppy period for OPKO Health’s stock, with the share price falling 5% over the past month but rising 29% across 90 days and delivering a 20% year to date share price return, while the 5 year total shareholder return remains deeply...","category":"company","datetime":1792260844,"headline":"OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides"}, {"id":142960890,"url":"https://finnhub.io/api/news?id=9a1a2d42a4ad170cd9dc89325daa0c86a99f42a731765646c2c00b3e44ce78a9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"OPKO Health has seen sharp swings over the past few years, and the stock now sits at US$1.53 with investors reassessing what its current sales actually support. With such a mixed share price history and a changing business mix, the question is how much of the story around its revenue base is already priced in. Over the past 5 years the share price has fallen 58.5%, which puts the focus firmly on whether the current market value still lines up with what OPKO Health generates from its...","category":"company","datetime":1792243004,"headline":"Is OPKO Health (OPK) Pricing In Too Much For Sales?"}, {"id":142948202,"url":"https://finnhub.io/api/news?id=be02199a10f304a0bb08807c018107b8f60d565dbbea85a5f0faa547d06a474e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"OPK's $722M BioReference asset sale to Labcorp, with a potential $150M earnout, aims to sharpen its biopharma focus and expand access to the 4Kscore Test.","category":"company","datetime":1792160400,"headline":"OPKO Health to Sell Select BioReference Assets to Labcorp for $722M"}, {"id":142944447,"url":"https://finnhub.io/api/news?id=31b89a5cc4bae365c4a8d4fd0bf842adf4e91b4753215e6f8d075c168fdeb752","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"PACS Group, Inc. (PACS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.","category":"company","datetime":1792147920,"headline":"PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?"}, {"id":142927482,"url":"https://finnhub.io/api/news?id=b3b6b829857bedfcd9e84d185005325194c4788fb14eb827248ae76412b9348f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings has delivered a strong share price run in recent years, so the key issue now is whether the current US$325.07 level is properly supported by the cash it can generate. With investors already sitting on sizeable gains, the question is how closely the recent price action lines up with the company’s underlying cash flow profile. Over the past 3 years the stock has returned 68.8%. This puts real weight on whether that gain aligns with the cash the business is expected to produce...","category":"company","datetime":1792113319,"headline":"Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook"}, {"id":142920356,"url":"https://finnhub.io/api/news?id=f4d0d8ba53bf9e25adccd37d206df4cda5c13771e990a08b66db3162adb5e07d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index rising 2.3% and the State","category":"company","datetime":1792086847,"headline":"Sector Update: Healthcare Stocks Gain Thursday Afternoon"}, {"id":142920665,"url":"https://finnhub.io/api/news?id=4cb99e4b164b6740ed4f3e1f3c25186c3c2160f5ed96c9f49ac720543e3359a9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and its peers.","category":"company","datetime":1792080507,"headline":"Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks"}, {"id":142916924,"url":"https://finnhub.io/api/news?id=e23ac0f1736c2e7ea14dfbc68a42599561c922408e9d1535d2a756bdb451a361","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Investing.com -- Opko Health Inc (NASDAQ:OPK) shares surged 20% in premarket trading Thursday after Labcorp Holdings Inc (NYSE:LH) agreed to acquire select assets of BioReference Health for $722 million in cash.","category":"company","datetime":1792071915,"headline":"Opko Health stock soars on $722M BioReference asset sale"}, {"id":142946568,"url":"https://finnhub.io/api/news?id=6bffe38642550716cf1dd5fc40295fd4671c79e94684106e85d04cb688551d8c","image":"https://cdn.benzinga.com/files/images/story/2026/10/15/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536","source":"Benzinga","related":"LH","summary":"OPKO Health jumps 18% and Labcorp trades higher as LH acquires BioReference Health assets in an $872M deal.","category":"company","datetime":1792064494,"headline":"OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal"}, {"id":142913417,"url":"https://finnhub.io/api/news?id=3d0a921340b3ae980145d04549df8850a1a0e6467130b5d88b8da7ec49332a05","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, LLC, a wholly owned subsidiary of OPKO Health.","category":"company","datetime":1792063800,"headline":"Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health"}, {"id":142917192,"url":"https://finnhub.io/api/news?id=ae59923ebafc3f8274009f0069d4fd704f4226d79457171e2d599ded76c68514","image":"","source":"Benzinga","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (NASDAQ:OPK), a multinational biopharmaceutical company, announced today that they have entered into an","category":"company","datetime":1792052464,"headline":"UPDATE: Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue"}, {"id":142917193,"url":"https://finnhub.io/api/news?id=b1414cdb5f2916631fd1cfedfc4f403a8427ed94cb84dd49ed012ebd838b3d13","image":"","source":"Benzinga","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (NASDAQ:OPK), a multinational biopharmaceutical company, announced today that they have entered into an","category":"company","datetime":1792049587,"headline":"Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue"}, {"id":142848797,"url":"https://finnhub.io/api/news?id=d8b97ec64552a3689972eaa7a4b082b14408a5c97865f7422bf130bd4d2c1121","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"ABT's Q3 earnings are likely to have benefited from Diagnostics growth, Medical Device momentum and Nutrition innovations, while its valuation below historical levels draw investor interest.","category":"company","datetime":1791893520,"headline":"Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?"}, {"id":142847667,"url":"https://finnhub.io/api/news?id=6fe31cfd0e993b1ae12145b19436f114bf522c4589f9be7690499d0e1f76238f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Thrive 5 Health Test, the first lab test offered in collaboration with Arianna Huffington's behavior change technology company, Thrive Global. Available through Labcorp OnDemand, the offering pairs trusted health insights from Labcorp with Thrive Global's behavior change approach, giving consumers a better understanding of their health and practical ways to improve it.","category":"company","datetime":1791892800,"headline":"Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test"}, {"id":142825442,"url":"https://finnhub.io/api/news?id=666239ff6707a01d9f688b18c57311f416bab30f6f16b2df1992840c04dfca3d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Investors holding Hims & Hers Health (HIMS) face a stark contradiction. The stock has lost 52% in twelve months, while the S&P 500 returned 17.0%. Following that decline, shares now trade at 2.8 times sales, against 3.1 for the index. Yet the company grew sales nearly 40% in fiscal Q2 2026. So where is that growth coming from.","category":"company","datetime":1791845626,"headline":"Should You Trim Or Add To Your Hims & Hers Position Now?"}, {"id":142823840,"url":"https://finnhub.io/api/news?id=ad666a9d8ce474aecb716a215046443d84cf1dca9d4edddca50d373c693188e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug development. Physicians, hospitals, and pharmaceutical companies provide different sources of demand, while personalized treatments create opportunities for more sophisticated testing. Capturing that demand requires spending on equipment, technology, and capacity before the resulting cash arrives. Insider Monkey lists […]","category":"company","datetime":1791828498,"headline":"Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?"}, {"id":142732294,"url":"https://finnhub.io/api/news?id=d03efa18c39b55938dc08f8f086d178f2d5a6ae70e5eb635c23a41e90297e8ff","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings is slated to report its third-quarter earnings later this month, and Wall Street expects its profit to rise at a lower-double-digit rate from a year ago.","category":"company","datetime":1791460845,"headline":"What to Expect From Labcorp Holdings’ Q3 2026 Earnings Report"}, {"id":142696923,"url":"https://finnhub.io/api/news?id=af7eb7e9c15b035c266b462cb988511c7c7c2a3a3d36b2283415d8f6e53bf30e","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1394005030/image_1394005030.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"LH","summary":"Natera is rated Sell, as its valuation is stretched, with perfect execution priced in, despite looming competitive threats. Click to read more about NTRA.","category":"company","datetime":1791373949,"headline":"Natera: Priced To Perfection Amidst Rising Competitive Threats"}, {"id":142635174,"url":"https://finnhub.io/api/news?id=309e39ced8683fbbaf7266081ace5e0747264bb70597b7d8146d9e026f922aa9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.","category":"company","datetime":1791205620,"headline":"2 Volatile Stocks to Consider Right Now and 1 We Find Risky"}, {"id":142520955,"url":"https://finnhub.io/api/news?id=e2604dbf0993dd1f23e0744dfaa41f51d914c805b65d90ba56ea29ffda04754b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Danaher's Biotechnology segment posts 4% sales growth, but tough comparisons and shipment timing could test its momentum.","category":"company","datetime":1790775060,"headline":"DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?"}, {"id":142516777,"url":"https://finnhub.io/api/news?id=5bd7947178006648b56c799daedc6ecd04a9c09c3d5a4b23fdcdd1147fdfab20","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2026 before the market opens on Wednesday, October 28, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the \"News & Events\" section of the Labcorp Investor Relations website at https://ir.labcorp.com. A li","category":"company","datetime":1790771400,"headline":"Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026"}, {"id":142496325,"url":"https://finnhub.io/api/news?id=0cb3b7a59e2b53ec28fac53ce599d82105816aba56b747dec364be56986af41f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.","category":"company","datetime":1790682240,"headline":"Is This the Right Time to Add Labcorp Stock to Your Portfolio?"}, {"id":142491829,"url":"https://finnhub.io/api/news?id=9f3e66b74fb7fec72306f86e596f56594e1b0cb1887229cc1c7dfa697db4d559","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.","category":"company","datetime":1790677442,"headline":"3 Low-Volatility Stocks That Concern Us"}, {"id":142363707,"url":"https://finnhub.io/api/news?id=c42be449053434616eb7e3e98291ef29fdcd4c553ad74bc7a15a4e0186a1f037","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442853868/image_1442853868.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"LH","summary":"Labcorp dives on CMS 2027 Medicare lab-payment cuts; see why the selloff may be overdone, and the downside capped and why it’s a strong buy of LH stock—read now.","category":"company","datetime":1790175492,"headline":"Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy"}, {"id":142356836,"url":"https://finnhub.io/api/news?id=fcbc25354f9fd091ac16986cc1e363a23ffce42f65a596ab4b5705eba6055c7e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings (NYSE:LH) used its 2026 Investor Day to outline a push into targeted acquisitions and new lab technologies. Management emphasized capital deployment toward advanced lab management systems and expanded digital experiences for patients and providers. The company highlighted plans to integrate acquired platforms with its existing diagnostic infrastructure to streamline operations and data handling. Labcorp's renewed focus on acquisitions and digital lab tools only tells part of...","category":"company","datetime":1790162032,"headline":"Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day"}, {"id":142356192,"url":"https://finnhub.io/api/news?id=90830fbeccc964599316a2d39aa66520a1802d2812377348dc9b72704d74a44e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.","category":"company","datetime":1790152622,"headline":"2 Small-Cap Stocks to Research Further and 1 Facing Challenges"}, {"id":142357293,"url":"https://finnhub.io/api/news?id=f028c3037a2555ba209c234d4f82ed4baa8339097b828fd027bd064fd55ce365","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings stock has outpaced the Dow this year, and analysts remain bullish about its prospects.","category":"company","datetime":1790144204,"headline":"Is Labcorp Holdings Stock Outperforming the Dow?"}, {"id":142342940,"url":"https://finnhub.io/api/news?id=e9807b65095e17e131c9ee86034d32f486a877338c98a14d3204993ab310e0d7","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260596586/image_2260596586.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"LH","summary":"Labcorp Holdings Inc. upgraded to Buy: resilient diagnostics demand, strong Q2, modest valuation and new tests offset Medicare cuts. Click for this LH update.","category":"company","datetime":1790099629,"headline":"Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts"}, {"id":142340992,"url":"https://finnhub.io/api/news?id=7f9451e056dd0c45a4304b88f0f9ccd9306f02bc7a8be5192dacae80dd8a134d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Stock Market Today: The Dow Jones index was lower after President Trump threatened Iran at the UN. Apple stock is near a buy point.","category":"company","datetime":1790098711,"headline":"Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)"}, {"id":142360825,"url":"https://finnhub.io/api/news?id=cb91d7185631c0a0ca0b623e175fc960d7e28e3b0e02f7970e425387fec3556d","image":"","source":"Benzinga","related":"LH","summary":"On September 21, 2026, the Centers for Medicare & Medicaid Services ("CMS") released preliminary Clinical Laboratory Fee Schedule payment rates applicable from 2027 through 2029 pursuant to the Protecting","category":"company","datetime":1790095610,"headline":"Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029"}, {"id":142339759,"url":"https://finnhub.io/api/news?id=29afb0d0da9a758635b415b21af875d0fd597d54c01f2d721169f070844a7f15","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"The government thinks it's been overpaying Labcorp. They plan to stop doing that next year.","category":"company","datetime":1790091849,"headline":"Why Labcorp Holdings Stock Dropped Today"}, {"id":142338104,"url":"https://finnhub.io/api/news?id=5215abeb2634d2e41b0915055aa5ef030cbf4b8eecbec9bed4a3c64d0351b745","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Quest Diagnostics (DGX) and Labcorp (LH) shares fell in Tuesday premarket trading after the Centers","category":"company","datetime":1790081212,"headline":"Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services"}, {"id":142337151,"url":"https://finnhub.io/api/news?id=ec15db9f3538528033e3a2b785c80a05463d3015aa798d3d099f3d82dfb34f1d","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"LH","summary":"Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.","category":"company","datetime":1790080501,"headline":"Discover the top S&P500 movers in Tuesday's pre-market session."}, {"id":142340903,"url":"https://finnhub.io/api/news?id=0038cdfe7ff456daae6d1d328d374892016f3ea30e0fa66c2020ba00ba32c252","image":"https://image.cnbcfm.com/api/v1/image/107419247-1716474869682-gettyimages-2120209340-64393_48_ms_2421.jpeg?v=1790098111&w=1920&h=1080","source":"CNBC","related":"LH","summary":"These are the stocks posting the largest moves midday.","category":"company","datetime":1790079522,"headline":"Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more"}, {"id":142336978,"url":"https://finnhub.io/api/news?id=f1182ee95aa158cd4e64c93fec0fe6aa89a804fc357f25c80bbb04d312374656","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Investing.com - U.S. stock index futures steadied on Tuesday, following a strong session on Wall Street that saw the benchmark S&P 500 post its best day since August, helped by gains in artificial intelligence-linked stocks.","category":"company","datetime":1790078144,"headline":"Premarket movers: Quest, Labcorp hit by CMS cuts"}, {"id":142338042,"url":"https://finnhub.io/api/news?id=5fbe59656eb7c8e519203883d87a9ba7e725d627ad9c93744d9bd2b9cb6b416c","image":"https://cdn.benzinga.com/files/images/story/2026/09/22/Stockholm--Sweden---October-8--2021-An-O.jpg?width=2048&height=1536","source":"Benzinga","related":"LH","summary":"U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostics, Rambus and others also declined premarket.","category":"company","datetime":1790064067,"headline":"Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session"}, {"id":142340847,"url":"https://finnhub.io/api/news?id=1a3dcec5e48d410e2b1bfe59cbaf3923fc48e925527b6fa1ef1214e10e7de391","image":"https://image.cnbcfm.com/api/v1/image/108192542-17564859632025-08-29t163100z_183075094_rc28ggaso5se_rtrmadp_0_on-hldg-results.jpeg?v=1756486078&w=1920&h=1080","source":"CNBC","related":"LH","summary":"These are the stocks posting the largest moves in early trading.","category":"company","datetime":1790063373,"headline":"Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more "}, {"id":142313759,"url":"https://finnhub.io/api/news?id=d91a7f0c3c1c18e244dd5cb3fa0b0a890f7e233f01fe15c910f07c32335c0348","image":"","source":"Benzinga","related":"LH","summary":"Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $350 to $365.","category":"company","datetime":1789981395,"headline":"Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365"}
data_source finnhub_news_keyword_model
article_count 4
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.6
source_article_count 38
discarded_article_count 34
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.3 5/110 66% 3.3
資金流 15.6 20/110 78% 15.6
市場環境 8 15/110 53.33% 8
催化劑 2 20/110 10% 2
風險管理 7.6 10/110 76% 7.6
技術信號 20.2 30/110 67.33% 20.2
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 9/50
ret_5d 0.0186
max_score 50
max_total 50
raw_total 9
vcp_bonus 0
vol_ratio 0.9192
ret_points 4
vol_points 0
range_ratio 1.8338
volat_points 4
day_range_pct 0.0358
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 1.9754
turnoverUsdM 224.4727
liquidityPoints 0.4
volatilityPoints 1.2
rrPoints 1.6

stopLevels

symbol US.LH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 305.3886

strength_details

ma_score 1
atr_score 2.5
rsi_score 3
macd_score 3
volume_score 1
market_adjustment 1
risk_reward_ratio 1.6
stop_loss_percent 4
take_profit_price 337.5249
target_multiplier 2.2
technical_strength 2.13
take_profit_percent 6.2
positionPoints 1.6
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.5693
stopLossPercent 3.9507
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.3/5分
資金流分析總分: 15.6/20分
市場環境分析總分: 8/15分
催化劑分析: 2/20分
風險管理總分: 7.6/10分
技術信號分析總分: 20.2/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 100
atr
atr 6.2807
rule ATR / current price; lower volatility scores higher
score 8
atr_pct 1.98
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 133.54
cmf
rule Cursor_18.24 CMF bands
level 平衡
score 4
value 0.0552
kdj
d 74.27
j 76.35
k 74.96
rule Cursor_18.24 K/D cross
score 6
signal 強金叉
mfi
rule Cursor_18.24 MFI bands
level 強資金流入
score 10
value 78.27
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 502500
recentSlope 199130
previousSlope -251410
rsi
value 60.37
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 303.9348
position SAR喺價下
distancePct 4.41
previousTrend 上升
ma50
value 320.4298
macd
macd 0.0723
trend 強烈看漲
signal -1.4951
histogram 1.5674
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 311.545
position 連續5日>VWAP
consecutiveAbove 5
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.99
score 4
avgVolume 716460
currentVolume 706000
derived
ma20 312.144
ma50 320.4298
prevClose 325.07
avgVolume10 623260
avgVolume20 716460
changePercent -2.19
avgVolumeForScore 716460
ma_cross
ma20 312.144
ma50 320.4298
rule Cursor_18.24 MA20/MA50 cross
cross 熊勢
score 0
prevMa20 312.282
prevMa50 320.4014
spreadPct 2.59
isVolumeBreakout false
bollinger
lower 301.9059
upper 322.3821
position 上半部
rsi_short
value 57.25
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.99

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 1.9753734242688024,
        "turnoverUsdM": 224.47270706,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1.2
      }
    },
    "rrPoints": 1.6,
    "stopLevels": {
      "symbol": "US.LH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 305.3886,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2.5,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.6,
      "stop_loss_percent": 4,
      "take_profit_price": 337.5249,
      "target_multiplier": 2.2,
      "technical_strength": 2.13,
      "take_profit_percent": 6.2
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.5693235324088082,
    "stopLossPercent": 3.9507468485376047,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 69.7,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.7,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 9
  },
  "market": {
    "ma20": 312.144,
    "ma50": 320.4298,
    "close": 317.95,
    "prevClose": 325.07,
    "avgVolume20": 716460,
    "volumeRatio": 0.99,
    "changePercent": -2.19
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 9,
    "details": {
      "ret_5d": 0.018580875174783795,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 9,
      "vcp_bonus": 0,
      "vol_ratio": 0.9192050048499131,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 1.833768938410786,
      "volat_points": 4,
      "day_range_pct": 0.03579179003642741,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 69.7,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 66,
        "contribution": 3.3
      },
      {
        "raw": 15.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 78,
        "contribution": 15.6
      },
      {
        "raw": 8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 53.33,
        "contribution": 8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 76,
        "contribution": 7.6
      },
      {
        "raw": 20.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 67.33,
        "contribution": 20.2
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.7,
    "details": [
      "基本面分析總分: 3.3/5分",
      "資金流分析總分: 15.6/20分",
      "市場環境分析總分: 8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.6/10分",
      "技術信號分析總分: 20.2/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.3,
      "資金流": 15.6,
      "市場環境": 8,
      "情緒分析": 4,
      "技術信號": 20.2,
      "風險管理": 7.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0.6,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 224.47270706,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 4,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.LH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.46
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 742.51900315,
                "ma50": 726.7734006600002,
                "name": "QQQ",
                "close": 709.79999,
                "points": 0.4
              },
              "spy": {
                "ma20": 771.1839966499999,
                "ma50": 768.5017965800001,
                "name": "SPY",
                "close": 763.25,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 1.9753734242688024,
          "atrPoints": 4,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142927482,
                "url": "https://finnhub.io/api/news?id=b3b6b829857bedfcd9e84d185005325194c4788fb14eb827248ae76412b9348f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings has delivered a strong share price run in recent years, so the key issue now is whether the current US$325.07 level is properly supported by the cash it can generate. With investors already sitting on sizeable gains, the question is how closely the recent price action lines up with the company’s underlying cash flow profile. Over the past 3 years the stock has returned 68.8%. This puts real weight on whether that gain aligns with the cash the business is expected to produce...",
                "category": "company",
                "datetime": 1792113319,
                "headline": "Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook"
              },
              {
                "id": 142920665,
                "url": "https://finnhub.io/api/news?id=4cb99e4b164b6740ed4f3e1f3c25186c3c2160f5ed96c9f49ac720543e3359a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and its peers.",
                "category": "company",
                "datetime": 1792080507,
                "headline": "Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks"
              },
              {
                "id": 142823840,
                "url": "https://finnhub.io/api/news?id=ad666a9d8ce474aecb716a215046443d84cf1dca9d4edddca50d373c693188e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug development. Physicians, hospitals, and pharmaceutical companies provide different sources of demand, while personalized treatments create opportunities for more sophisticated testing. Capturing that demand requires spending on equipment, technology, and capacity before the resulting cash arrives. Insider Monkey lists […]",
                "category": "company",
                "datetime": 1791828498,
                "headline": "Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?"
              },
              {
                "id": 142356836,
                "url": "https://finnhub.io/api/news?id=fcbc25354f9fd091ac16986cc1e363a23ffce42f65a596ab4b5705eba6055c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE:LH) used its 2026 Investor Day to outline a push into targeted acquisitions and new lab technologies. Management emphasized capital deployment toward advanced lab management systems and expanded digital experiences for patients and providers. The company highlighted plans to integrate acquired platforms with its existing diagnostic infrastructure to streamline operations and data handling. Labcorp's renewed focus on acquisitions and digital lab tools only tells part of...",
                "category": "company",
                "datetime": 1790162032,
                "headline": "Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day"
              }
            ],
            "raw_source": [
              {
                "id": 142963267,
                "url": "https://finnhub.io/api/news?id=e20118b395c1fcab44866a321e7779c08eee6a67d07be0aaff04f641386c736e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "OPKO Health (OPK) drew fresh attention after agreeing to sell select BioReference Health assets to Labcorp in a deal valued at up to US$872 million, a move that could reshape its diagnostics footprint and capital allocation priorities. The deal news arrived after a choppy period for OPKO Health’s stock, with the share price falling 5% over the past month but rising 29% across 90 days and delivering a 20% year to date share price return, while the 5 year total shareholder return remains deeply...",
                "category": "company",
                "datetime": 1792260844,
                "headline": "OPKO Health (OPK) Sells BioReference Assets On A Valuation Story That Still Divides"
              },
              {
                "id": 142960890,
                "url": "https://finnhub.io/api/news?id=9a1a2d42a4ad170cd9dc89325daa0c86a99f42a731765646c2c00b3e44ce78a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "OPKO Health has seen sharp swings over the past few years, and the stock now sits at US$1.53 with investors reassessing what its current sales actually support. With such a mixed share price history and a changing business mix, the question is how much of the story around its revenue base is already priced in. Over the past 5 years the share price has fallen 58.5%, which puts the focus firmly on whether the current market value still lines up with what OPKO Health generates from its...",
                "category": "company",
                "datetime": 1792243004,
                "headline": "Is OPKO Health (OPK) Pricing In Too Much For Sales?"
              },
              {
                "id": 142948202,
                "url": "https://finnhub.io/api/news?id=be02199a10f304a0bb08807c018107b8f60d565dbbea85a5f0faa547d06a474e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "OPK's $722M BioReference asset sale to Labcorp, with a potential $150M earnout, aims to sharpen its biopharma focus and expand access to the 4Kscore Test.",
                "category": "company",
                "datetime": 1792160400,
                "headline": "OPKO Health to Sell Select BioReference Assets to Labcorp for $722M"
              },
              {
                "id": 142944447,
                "url": "https://finnhub.io/api/news?id=31b89a5cc4bae365c4a8d4fd0bf842adf4e91b4753215e6f8d075c168fdeb752",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "PACS Group, Inc. (PACS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.",
                "category": "company",
                "datetime": 1792147920,
                "headline": "PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?"
              },
              {
                "id": 142927482,
                "url": "https://finnhub.io/api/news?id=b3b6b829857bedfcd9e84d185005325194c4788fb14eb827248ae76412b9348f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings has delivered a strong share price run in recent years, so the key issue now is whether the current US$325.07 level is properly supported by the cash it can generate. With investors already sitting on sizeable gains, the question is how closely the recent price action lines up with the company’s underlying cash flow profile. Over the past 3 years the stock has returned 68.8%. This puts real weight on whether that gain aligns with the cash the business is expected to produce...",
                "category": "company",
                "datetime": 1792113319,
                "headline": "Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook"
              },
              {
                "id": 142920356,
                "url": "https://finnhub.io/api/news?id=f4d0d8ba53bf9e25adccd37d206df4cda5c13771e990a08b66db3162adb5e07d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index rising 2.3% and the State",
                "category": "company",
                "datetime": 1792086847,
                "headline": "Sector Update: Healthcare Stocks Gain Thursday Afternoon"
              },
              {
                "id": 142920665,
                "url": "https://finnhub.io/api/news?id=4cb99e4b164b6740ed4f3e1f3c25186c3c2160f5ed96c9f49ac720543e3359a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and its peers.",
                "category": "company",
                "datetime": 1792080507,
                "headline": "Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks"
              },
              {
                "id": 142916924,
                "url": "https://finnhub.io/api/news?id=e23ac0f1736c2e7ea14dfbc68a42599561c922408e9d1535d2a756bdb451a361",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Investing.com -- Opko Health Inc (NASDAQ:OPK) shares surged 20% in premarket trading Thursday after Labcorp Holdings Inc (NYSE:LH) agreed to acquire select assets of BioReference Health for $722 million in cash.",
                "category": "company",
                "datetime": 1792071915,
                "headline": "Opko Health stock soars on $722M BioReference asset sale"
              },
              {
                "id": 142946568,
                "url": "https://finnhub.io/api/news?id=6bffe38642550716cf1dd5fc40295fd4671c79e94684106e85d04cb688551d8c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/15/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "LH",
                "summary": "OPKO Health jumps 18% and Labcorp trades higher as LH acquires BioReference Health assets in an $872M deal.",
                "category": "company",
                "datetime": 1792064494,
                "headline": "OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal"
              },
              {
                "id": 142913417,
                "url": "https://finnhub.io/api/news?id=3d0a921340b3ae980145d04549df8850a1a0e6467130b5d88b8da7ec49332a05",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, LLC, a wholly owned subsidiary of OPKO Health.",
                "category": "company",
                "datetime": 1792063800,
                "headline": "Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health"
              },
              {
                "id": 142917192,
                "url": "https://finnhub.io/api/news?id=ae59923ebafc3f8274009f0069d4fd704f4226d79457171e2d599ded76c68514",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (NASDAQ:OPK), a multinational biopharmaceutical company, announced today that they have entered into an",
                "category": "company",
                "datetime": 1792052464,
                "headline": "UPDATE: Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue"
              },
              {
                "id": 142917193,
                "url": "https://finnhub.io/api/news?id=b1414cdb5f2916631fd1cfedfc4f403a8427ed94cb84dd49ed012ebd838b3d13",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (NASDAQ:OPK), a multinational biopharmaceutical company, announced today that they have entered into an",
                "category": "company",
                "datetime": 1792049587,
                "headline": "Labcorp Agrees To Acquire Select Assets Of OPKO Health's BioReference Health Subsidiary For $722M In Cash, Up To Additional $150M In Earnout On Revenue"
              },
              {
                "id": 142848797,
                "url": "https://finnhub.io/api/news?id=d8b97ec64552a3689972eaa7a4b082b14408a5c97865f7422bf130bd4d2c1121",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "ABT's Q3 earnings are likely to have benefited from Diagnostics growth, Medical Device momentum and Nutrition innovations, while its valuation below historical levels draw investor interest.",
                "category": "company",
                "datetime": 1791893520,
                "headline": "Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?"
              },
              {
                "id": 142847667,
                "url": "https://finnhub.io/api/news?id=6fe31cfd0e993b1ae12145b19436f114bf522c4589f9be7690499d0e1f76238f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Thrive 5 Health Test, the first lab test offered in collaboration with Arianna Huffington's behavior change technology company, Thrive Global. Available through Labcorp OnDemand, the offering pairs trusted health insights from Labcorp with Thrive Global's behavior change approach, giving consumers a better understanding of their health and practical ways to improve it.",
                "category": "company",
                "datetime": 1791892800,
                "headline": "Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test"
              },
              {
                "id": 142825442,
                "url": "https://finnhub.io/api/news?id=666239ff6707a01d9f688b18c57311f416bab30f6f16b2df1992840c04dfca3d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Investors holding Hims & Hers Health (HIMS) face a stark contradiction. The stock has lost 52% in twelve months, while the S&P 500 returned 17.0%. Following that decline, shares now trade at 2.8 times sales, against 3.1 for the index. Yet the company grew sales nearly 40% in fiscal Q2 2026. So where is that growth coming from.",
                "category": "company",
                "datetime": 1791845626,
                "headline": "Should You Trim Or Add To Your Hims & Hers Position Now?"
              },
              {
                "id": 142823840,
                "url": "https://finnhub.io/api/news?id=ad666a9d8ce474aecb716a215046443d84cf1dca9d4edddca50d373c693188e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE:LH) earns fees from routine and specialty medical tests and laboratory services supporting drug development. Physicians, hospitals, and pharmaceutical companies provide different sources of demand, while personalized treatments create opportunities for more sophisticated testing. Capturing that demand requires spending on equipment, technology, and capacity before the resulting cash arrives. Insider Monkey lists […]",
                "category": "company",
                "datetime": 1791828498,
                "headline": "Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?"
              },
              {
                "id": 142732294,
                "url": "https://finnhub.io/api/news?id=d03efa18c39b55938dc08f8f086d178f2d5a6ae70e5eb635c23a41e90297e8ff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings is slated to report its third-quarter earnings later this month, and Wall Street expects its profit to rise at a lower-double-digit rate from a year ago.",
                "category": "company",
                "datetime": 1791460845,
                "headline": "What to Expect From Labcorp Holdings’ Q3 2026 Earnings Report"
              },
              {
                "id": 142696923,
                "url": "https://finnhub.io/api/news?id=af7eb7e9c15b035c266b462cb988511c7c7c2a3a3d36b2283415d8f6e53bf30e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1394005030/image_1394005030.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Natera is rated Sell, as its valuation is stretched, with perfect execution priced in, despite looming competitive threats. Click to read more about NTRA.",
                "category": "company",
                "datetime": 1791373949,
                "headline": "Natera: Priced To Perfection Amidst Rising Competitive Threats"
              },
              {
                "id": 142635174,
                "url": "https://finnhub.io/api/news?id=309e39ced8683fbbaf7266081ace5e0747264bb70597b7d8146d9e026f922aa9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.",
                "category": "company",
                "datetime": 1791205620,
                "headline": "2 Volatile Stocks to Consider Right Now and 1 We Find Risky"
              },
              {
                "id": 142520955,
                "url": "https://finnhub.io/api/news?id=e2604dbf0993dd1f23e0744dfaa41f51d914c805b65d90ba56ea29ffda04754b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Danaher's Biotechnology segment posts 4% sales growth, but tough comparisons and shipment timing could test its momentum.",
                "category": "company",
                "datetime": 1790775060,
                "headline": "DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?"
              },
              {
                "id": 142516777,
                "url": "https://finnhub.io/api/news?id=5bd7947178006648b56c799daedc6ecd04a9c09c3d5a4b23fdcdd1147fdfab20",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2026 before the market opens on Wednesday, October 28, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the \"News & Events\" section of the Labcorp Investor Relations website at https://ir.labcorp.com. A li",
                "category": "company",
                "datetime": 1790771400,
                "headline": "Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026"
              },
              {
                "id": 142496325,
                "url": "https://finnhub.io/api/news?id=0cb3b7a59e2b53ec28fac53ce599d82105816aba56b747dec364be56986af41f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.",
                "category": "company",
                "datetime": 1790682240,
                "headline": "Is This the Right Time to Add Labcorp Stock to Your Portfolio?"
              },
              {
                "id": 142491829,
                "url": "https://finnhub.io/api/news?id=9f3e66b74fb7fec72306f86e596f56594e1b0cb1887229cc1c7dfa697db4d559",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.",
                "category": "company",
                "datetime": 1790677442,
                "headline": "3 Low-Volatility Stocks That Concern Us"
              },
              {
                "id": 142363707,
                "url": "https://finnhub.io/api/news?id=c42be449053434616eb7e3e98291ef29fdcd4c553ad74bc7a15a4e0186a1f037",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442853868/image_1442853868.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp dives on CMS 2027 Medicare lab-payment cuts; see why the selloff may be overdone, and the downside capped and why it’s a strong buy of LH stock—read now.",
                "category": "company",
                "datetime": 1790175492,
                "headline": "Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy"
              },
              {
                "id": 142356836,
                "url": "https://finnhub.io/api/news?id=fcbc25354f9fd091ac16986cc1e363a23ffce42f65a596ab4b5705eba6055c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE:LH) used its 2026 Investor Day to outline a push into targeted acquisitions and new lab technologies. Management emphasized capital deployment toward advanced lab management systems and expanded digital experiences for patients and providers. The company highlighted plans to integrate acquired platforms with its existing diagnostic infrastructure to streamline operations and data handling. Labcorp's renewed focus on acquisitions and digital lab tools only tells part of...",
                "category": "company",
                "datetime": 1790162032,
                "headline": "Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day"
              },
              {
                "id": 142356192,
                "url": "https://finnhub.io/api/news?id=90830fbeccc964599316a2d39aa66520a1802d2812377348dc9b72704d74a44e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.",
                "category": "company",
                "datetime": 1790152622,
                "headline": "2 Small-Cap Stocks to Research Further and 1 Facing Challenges"
              },
              {
                "id": 142357293,
                "url": "https://finnhub.io/api/news?id=f028c3037a2555ba209c234d4f82ed4baa8339097b828fd027bd064fd55ce365",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings stock has outpaced the Dow this year, and analysts remain bullish about its prospects.",
                "category": "company",
                "datetime": 1790144204,
                "headline": "Is Labcorp Holdings Stock Outperforming the Dow?"
              },
              {
                "id": 142342940,
                "url": "https://finnhub.io/api/news?id=e9807b65095e17e131c9ee86034d32f486a877338c98a14d3204993ab310e0d7",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260596586/image_2260596586.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. upgraded to Buy: resilient diagnostics demand, strong Q2, modest valuation and new tests offset Medicare cuts. Click for this LH update.",
                "category": "company",
                "datetime": 1790099629,
                "headline": "Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts"
              },
              {
                "id": 142340992,
                "url": "https://finnhub.io/api/news?id=7f9451e056dd0c45a4304b88f0f9ccd9306f02bc7a8be5192dacae80dd8a134d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Stock Market Today: The Dow Jones index was lower after President Trump threatened Iran at the UN. Apple stock is near a buy point.",
                "category": "company",
                "datetime": 1790098711,
                "headline": "Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)"
              },
              {
                "id": 142360825,
                "url": "https://finnhub.io/api/news?id=cb91d7185631c0a0ca0b623e175fc960d7e28e3b0e02f7970e425387fec3556d",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "On September 21, 2026, the Centers for Medicare & Medicaid Services ("CMS") released preliminary Clinical Laboratory Fee Schedule payment rates applicable from 2027 through 2029 pursuant to the Protecting",
                "category": "company",
                "datetime": 1790095610,
                "headline": "Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029"
              },
              {
                "id": 142339759,
                "url": "https://finnhub.io/api/news?id=29afb0d0da9a758635b415b21af875d0fd597d54c01f2d721169f070844a7f15",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "The government thinks it's been overpaying Labcorp. They plan to stop doing that next year.",
                "category": "company",
                "datetime": 1790091849,
                "headline": "Why Labcorp Holdings Stock Dropped Today"
              },
              {
                "id": 142338104,
                "url": "https://finnhub.io/api/news?id=5215abeb2634d2e41b0915055aa5ef030cbf4b8eecbec9bed4a3c64d0351b745",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Quest Diagnostics (DGX) and Labcorp (LH) shares fell in Tuesday premarket trading after the Centers",
                "category": "company",
                "datetime": 1790081212,
                "headline": "Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services"
              },
              {
                "id": 142337151,
                "url": "https://finnhub.io/api/news?id=ec15db9f3538528033e3a2b785c80a05463d3015aa798d3d099f3d82dfb34f1d",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "LH",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.",
                "category": "company",
                "datetime": 1790080501,
                "headline": "Discover the top S&P500 movers in Tuesday's pre-market session."
              },
              {
                "id": 142340903,
                "url": "https://finnhub.io/api/news?id=0038cdfe7ff456daae6d1d328d374892016f3ea30e0fa66c2020ba00ba32c252",
                "image": "https://image.cnbcfm.com/api/v1/image/107419247-1716474869682-gettyimages-2120209340-64393_48_ms_2421.jpeg?v=1790098111&w=1920&h=1080",
                "source": "CNBC",
                "related": "LH",
                "summary": "These are the stocks posting the largest moves midday.",
                "category": "company",
                "datetime": 1790079522,
                "headline": "Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more"
              },
              {
                "id": 142336978,
                "url": "https://finnhub.io/api/news?id=f1182ee95aa158cd4e64c93fec0fe6aa89a804fc357f25c80bbb04d312374656",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Investing.com - U.S. stock index futures steadied on Tuesday, following a strong session on Wall Street that saw the benchmark S&P 500 post its best day since August, helped by gains in artificial intelligence-linked stocks.",
                "category": "company",
                "datetime": 1790078144,
                "headline": "Premarket movers: Quest, Labcorp hit by CMS cuts"
              },
              {
                "id": 142338042,
                "url": "https://finnhub.io/api/news?id=5fbe59656eb7c8e519203883d87a9ba7e725d627ad9c93744d9bd2b9cb6b416c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Stockholm--Sweden---October-8--2021-An-O.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "LH",
                "summary": "U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostics, Rambus and others also declined premarket.",
                "category": "company",
                "datetime": 1790064067,
                "headline": "Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session"
              },
              {
                "id": 142340847,
                "url": "https://finnhub.io/api/news?id=1a3dcec5e48d410e2b1bfe59cbaf3923fc48e925527b6fa1ef1214e10e7de391",
                "image": "https://image.cnbcfm.com/api/v1/image/108192542-17564859632025-08-29t163100z_183075094_rc28ggaso5se_rtrmadp_0_on-hldg-results.jpeg?v=1756486078&w=1920&h=1080",
                "source": "CNBC",
                "related": "LH",
                "summary": "These are the stocks posting the largest moves in early trading.",
                "category": "company",
                "datetime": 1790063373,
                "headline": "Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more "
              },
              {
                "id": 142313759,
                "url": "https://finnhub.io/api/news?id=d91a7f0c3c1c18e244dd5cb3fa0b0a890f7e233f01fe15c910f07c32335c0348",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Truist Securities  analyst David Macdonald   maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $350 to $365.",
                "category": "company",
                "datetime": 1789981395,
                "headline": "Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $365"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 4,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 38,
            "discarded_article_count": 34
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 20.2,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.4,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.4,
            "vcp_reason": "靠近20日高位;Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 755796.6666666666,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 611480,
              "avg_vol_20": 768055,
              "avg_vol_30": 755796.6666666666,
              "range_pct_10": 0.07057713254986216,
              "range_pct_20": 0.07057713254986216,
              "range_pct_30": 0.1038842552639013,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8090535814306318,
              "dist_to_20d_high": 0.02214356518971439,
              "down_shrink_days": 2,
              "breakout_level_20d": 325.14999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.6793823796548598
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 1.9753734242688024,
              "turnoverUsdM": 224.47270706,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1.2
            }
          },
          "rrPoints": 1.6,
          "stopLevels": {
            "symbol": "US.LH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 305.3886,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2.5,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.6,
            "stop_loss_percent": 4,
            "take_profit_price": 337.5249,
            "target_multiplier": 2.2,
            "technical_strength": 2.13,
            "take_profit_percent": 6.2
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.5693235324088082,
          "stopLossPercent": 3.9507468485376047,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 6.2807,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 8,
      "atr_pct": 1.98
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 133.54
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0552
    },
    "kdj": {
      "d": 74.27,
      "j": 76.35,
      "k": 74.96,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "強資金流入",
      "score": 10,
      "value": 78.27
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 502500,
      "recentSlope": 199130,
      "previousSlope": -251410
    },
    "rsi": 60.37,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 303.9348,
      "position": "SAR喺價下",
      "distancePct": 4.41,
      "previousTrend": "上升"
    },
    "ma50": 320.4298,
    "macd": {
      "macd": 0.0722975579644185,
      "trend": "強烈看漲",
      "signal": -1.4950610002429703,
      "histogram": 1.5673585582073888
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 311.545,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 5
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.99,
      "score": 4,
      "avgVolume": 716460,
      "currentVolume": 706000
    },
    "derived": {
      "ma20": 312.144,
      "ma50": 320.4298,
      "prevClose": 325.07,
      "avgVolume10": 623260,
      "avgVolume20": 716460,
      "changePercent": -2.19,
      "avgVolumeForScore": 716460
    },
    "ma_cross": {
      "ma20": 312.144,
      "ma50": 320.4298,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 312.282,
      "prevMa50": 320.4014,
      "spreadPct": 2.59,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 301.9059,
      "upper": 322.3821,
      "position": "上半部"
    },
    "rsi_short": 57.25,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.99
    }
  }
}

Raw metrics JSON

{
  "close": 317.95,
  "volume": 706000,
  "changePercent": -2.19
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.